IMMUNOPHARMACOLOGY OF RAPAMYCIN
- 1 April 1996
- journal article
- review article
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 14 (1) , 483-510
- https://doi.org/10.1146/annurev.immunol.14.1.483
Abstract
▪ Abstract The potent immunosuppressive drugs FK506 and rapamycin interfere with signal transduction pathways required for T cell activation and growth. The distinct inhibitory effects of these dru...Keywords
This publication has 121 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- Control of PHAS-I by Insulin in 3T3-L1 AdipocytesJournal of Biological Chemistry, 1995
- A Putative Sirolimus (Rapamycin) Effector ProteinBiochemical and Biophysical Research Communications, 1994
- Molecular Cloning and Expression of a Novel Human Gene That Is Highly Homologous to Human FK506-Binding Protein 12kDa (hFJBP-12) and Characterization of Two Alternatively Spliced TranscriptsBiochemical and Biophysical Research Communications, 1994
- Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progressionCell, 1993
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991
- TOXICITY OF RAPAMYCIN—A COMPARATIVE AND COMBINATION STUDY WITH CYCLOSPORINE AT IMMUNOTHERAPEUTIC DOSAGE IN THE RATTransplantation, 1991
- Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.Proceedings of the National Academy of Sciences, 1990
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975